French and German health authorities are warning against the use of Moderna’s experimental Spikevax Covid-19 vaccine for people under the age of 30 in light of evidence the shot wages higher risk of heart disease.
QUICK FACTS:
- A German advisory committee, known as STIKO, cited findings showing that experimental vaccines using mRNA technology were associated with an increased risk of hospitalization for myocarditis (inflammation of the heart muscle), and pericarditis (inflammation of the tissue surrounding the heart), in younger patients, according to The Epoch Times.
- Findings showed higher prevalence in those who received Moderna’s jab.
- Germany’s findings are similar to a study published on Nov 8 by France’s Epi-Phare.
- France’s public health authority also recommended people under 30 not receive Moderna Inc.’s Spikevax jab, which carried comparatively higher risks of heart-related problems, notes Reuters.
- France’s Haute Autorite de Sante (HAS) cited risks linked to Myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday.
